VEGF In Systemic Circulation Of ROP-infants

University Hospital Freiburg

Status: Withdrawn

Conditions: Retinopathy of Prematurity (ROP)

Study type: Observational

Funder types: Other

Identifiers

NCT01470430

VISOR Study

Details and patient eligibility

About

The purpose of this study is to measure systemic levels of vascular endothelial growth factor (VEGF) and other proteins (e.g. IGF-1) in the systemic circulation of infants with retinopathy of prematurity (ROP) following ocular treatment with either intravitreal injections of anti-VEGF agents or retinal laser photocoagulation. The primary aim is to determine if serum VEGF levels change after treatment.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of retinopathy of prematurity requiring treatment

Exclusion criteria

• Anemia

Trial design

0 participants in 2 patient groups

ROP infants treated with intravitreal anti-VEGF agents

ROP infants treated with retinal laser photocoagulation